Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6644748rdf:typepubmed:Citationlld:pubmed
pubmed-article:6644748lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:6644748lifeskim:mentionsumls-concept:C0700307lld:lifeskim
pubmed-article:6644748lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:6644748lifeskim:mentionsumls-concept:C0240795lld:lifeskim
pubmed-article:6644748lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:6644748pubmed:issue12lld:pubmed
pubmed-article:6644748pubmed:dateCreated1984-1-7lld:pubmed
pubmed-article:6644748pubmed:abstractTextN-Arylhydroxamic acid N,O-acyltransferase (AHAT) is a cytosolic enzyme system that is capable of converting toxic and carcinogenic N-arylhydroxamic acids into electrophilic reactants and of catalyzing the transacetylation of arylamines. The role of the N-hydroxyl group in promoting AHAT-catalyzed transacetylation of arylamines was investigated by the synthesis and biochemical evaluation of a series of o-hydroxyaryl amides and N-arylglycolamides. Several of these compounds are metabolites of carcinogenic aryl amides in vivo. 3-Hydroxy-4-acetamidobiphenyl (8) was weakly effective as an acetyl donor when partially purified preparations of hamster or rat hepatic AHAT were used to catalyze the transacetylation of 4-aminoazobenzene. 1-Hydroxy-2-acetamidofluorene (1), 3-hydroxy-2-acetamidofluorene (2), 2-glycolamidofluorene (3), 4-glycolamidobiphenyl (9), and trans-4-glycolamidostilbene (5) were less effective acyl donors than 4-acetamidobiphenyl (7) itself. The compounds were also assayed for their abilities to participate in the AHAT-catalyzed conveydroxy-2-acetamidofluorene (1), 3-hydroxy-2-acetamidofluorene (2), 2-glycolamidofluorene (3), 4-glycolamidobiphenyl (9), and trans-4-glycolamidostilbene (5) were less effective acyl donors than 4-acetamidobiphenyl (7) itself. The compounds were also assayed for their abilities to participate in the AHAT-catalyzed conveydroxy-2-acetamidofluorene (1), 3-hydroxy-2-acetamidofluorene (2), 2-glycolamidofluorene (3), 4-glycolamidobiphenyl (9), and trans-4-glycolamidostilbene (5) were less effective acyl donors than 4-acetamidobiphenyl (7) itself. The compounds were also assayed for their abilities to participate in the AHAT-catalyzed conversion of N-arylhydroxylamines to electrophilic intermediates that form methylthio adducts upon reaction with N-acetylmethionine. None of the compounds exhibited more than 4% of the activity of the prototype compound, N-hydroxy-4-acetamidobiphenyl (10). These results indicate that the presence of an hydroxyl group on the ring position ortho to the amide group or on the alpha-position of the acyl group is not sufficient to confer significant acyltransferase activity with AHAT.lld:pubmed
pubmed-article:6644748pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:languageenglld:pubmed
pubmed-article:6644748pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:citationSubsetIMlld:pubmed
pubmed-article:6644748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6644748pubmed:statusMEDLINElld:pubmed
pubmed-article:6644748pubmed:monthDeclld:pubmed
pubmed-article:6644748pubmed:issn0022-2623lld:pubmed
pubmed-article:6644748pubmed:authorpubmed-author:HannaP EPElld:pubmed
pubmed-article:6644748pubmed:authorpubmed-author:SmithT JTJlld:pubmed
pubmed-article:6644748pubmed:authorpubmed-author:BanksR BRBlld:pubmed
pubmed-article:6644748pubmed:issnTypePrintlld:pubmed
pubmed-article:6644748pubmed:volume26lld:pubmed
pubmed-article:6644748pubmed:ownerNLMlld:pubmed
pubmed-article:6644748pubmed:authorsCompleteYlld:pubmed
pubmed-article:6644748pubmed:pagination1780-4lld:pubmed
pubmed-article:6644748pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:meshHeadingpubmed-meshheading:6644748-...lld:pubmed
pubmed-article:6644748pubmed:year1983lld:pubmed
pubmed-article:6644748pubmed:articleTitleN-arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group.lld:pubmed
pubmed-article:6644748pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6644748pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6644748lld:chembl